iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sun Pharmaceuticals Industries Ltd Option Chain

1,687.8
(0.02%)
Jun 13, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,400₹0.25 0%80,8501.31%
--1,420₹0.3 0%38,500-1.78%
--1,440₹0.2 -20%1,75,0000%
--1,480₹0.6 20%43,050-3.14%
7000%₹194.4 0%1,500₹0.85 6.24%1,48,0501.43%
--1,520₹1.1 10%27,3004%
--1,540₹1.45 16%85,400-8.95%
25,2000%₹135.25 0%1,560₹2.05 -2.38%87,1507.32%
14,3500%₹99.9 0%1,580₹3 -3.22%1,54,0001.14%
87,500-26.03%₹93.85 -4.47%1,600₹4.85 1.04%7,23,100-7.22%
26,2500%₹76.95 -4.64%1,620₹6.7 -1.47%1,98,1000.89%
93,1009.46%₹60.15 -6.08%1,640₹10.05 1%3,53,50010.02%
3,40,9008.94%₹45.5 -6.66%1,660₹15.15 2.36%6,06,9009.05%
4,63,40010.51%₹32.95 -8.47%1,680₹22.3 2.05%7,26,2501.71%
18,12,30015.24%₹23 -9.98%1,700₹32.35 2.37%6,31,400-2.64%
13,46,80045.64%₹15.45 -11.2%1,720₹44.55 2.76%96,950-23.69%
9,49,200-3.38%₹9.75 -14.84%1,740₹62.45 8.42%67,900-17.09%
4,49,050-9.26%₹6.5 -15.58%1,760₹78.75 7.87%52,8501.34%
1,59,6004.58%₹4.45 -15.23%1,780₹92.25 2.21%10,500-6.25%
7,99,050-1.04%₹3.25 -10.95%1,800₹112.1 2.79%62,65011.18%
1,73,250-1.19%₹2.3 -11.53%1,820₹125.85 0%1,0500%
1,24,600-0.55%₹1.6 -13.51%1,840₹150 0%3500%
1,49,100-4.69%₹1.05 -19.23%1,860--
74,9004.39%₹0.8 -23.8%1,880--
2,81,050-2.66%₹0.7 -12.5%1,900₹189.35 0%15,0500%
1,09,5500%₹0.35 -41.66%1,920--
17,1500%₹0.35 -36.36%1,940--
5,2500%₹0.7 0%1,960--
7,7000%₹0.5 -16.66%1,980--
5,85,900-0.05%₹0.4 -20%2,000--
12,6000%₹0.3 0%2,080--

Sun Pharma.Inds.: Related NEWS

Top Stocks for Today - 16th June 2025
16 Jun 2025|06:23 AM

Here are some of the stocks that may see significant price movement today: Sun Pharma, Vedanta, SpiceJet, etc.

Read More
US FDA Flags 8 Observations at Sun Pharma’s Halol Facility After GMP Inspection
15 Jun 2025|11:50 PM

The visit lasted from June 2 to June 13 and focused on checking for compliance with Good Manufacturing Practices.

Read More
Sun Pharma Expands Specialty Drug Pipeline with $25 Million Pharmazz Deal
24 May 2025|07:51 PM

Both treatments have already received approvals in India and are available for sale there with local partners under a brand known as Tyvalzi and Lyfaquin.

Read More
Sun Pharma Q4 FY25 Revenue Rises 8.5% to ₹12,816 Crore
23 May 2025|12:07 PM

The Board recommended a final dividend of ₹5.50 per share for FY25.

Read More
Top Stocks for Today - 7th May 2025
7 May 2025|08:06 AM

NLC's subsidiary has executed a PPA with Rajasthan Rajya Vidyut Utpadan Nigam Ltd. (RVUNL) for 810 MW solar power plant at Pugal Solar Park, Rajasthan

Read More
Sun Pharma’s MM-II Trial Shows Long-Lasting Relief for Knee Osteoarthritis
26 Apr 2025|01:15 PM

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

Read More
Sun Pharma to Acquire Nasdaq-Listed Checkpoint Therapeutics for $355 Million
10 Mar 2025|10:46 AM

The deal is expected to be completed in the second quarter of 2025, subject to customary closing conditions and regulatory approvals.

Read More
Sun Pharma Q3 Profit Jumps 19% YoY, Declares ₹10.50 Dividend
31 Jan 2025|10:17 PM

An interim dividend of ₹10.50 on the face value per share for FY25 has been declared.

Read More
Sun Pharma reports Q2 net profit at ₹3,040 Crore
29 Oct 2024|10:30 AM

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

Read More
Sun Pharma's Hair Loss Drug Approved by USFDA
26 Jul 2024|01:45 PM

The US Food and Drug Administration (USFDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets, according to a regulatory filing.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.